Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic

Lancet. 1999 Nov 6;354(9190):1615. doi: 10.1016/S0140-6736(99)03105-0.

Abstract

Cyclo-oxygenase-type-2 (COX-2) enzyme is fundamental for nephrogenesis, upregulated on fetal membranes and myometrium at parturition. Fetal COX-2 inhibition, due to maternal nimesulide assumption, can be responsible for neonatal chronic renal failure.

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Cyclooxygenase Inhibitors / adverse effects*
  • Female
  • Humans
  • Infant, Newborn
  • Kidney Failure, Chronic / chemically induced*
  • Obstetric Labor, Premature / prevention & control*
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Sulfonamides / adverse effects*

Substances

  • Cyclooxygenase Inhibitors
  • Sulfonamides
  • nimesulide